Billionaire physician and medical entrepreneur Patrick Soon-Shiong, MD, is facing criticism for reportedly boosting sales of his GPS Cancer genetic tests by citing positive experiences from three physicians with financial ties to one of his biotech companies, according to Politico.
A team of researchers from Atlanta-based Georgia Institute of Technology introduced an open-source algorithm Oct. 26 that predicts a cancer drug's effectiveness based on a patient's genetic data.
Long-term opioid use does not increase risk of developing Alzheimer's disease, according to a study published in Pain Medicine.
Danville, Pa.-based Geisinger Health System and pharmaceutical company Boehringer Ingelheim joined forces to create a predictive model to improve health outcomes for Type 2 diabetes patients, the companies announced Sept. 25.
Bloomfield, Conn.-based Cigna will remove OxyContin from its covered drug list Jan. 1.
In 2015, opioids accounted for more than two-thirds of all drug overdose deaths in the United States -- 15.6 percent more than the previous year -- and drug overdose deaths nearly tripled between 1999 and 2014.
A third of Americans check the cost of a prescription before filling: Prescription drug adherence lags among Americans with more formal education, higher income
Intermountain Precision Genomics, a St. George, Utah-based lab of Salt Lake City-based Intermountain Healthcare, launched the DNA-based RxMatch Anti-Depressant Panel Sept. 5.
The opioid epidemic is a complex issue that will require a multipronged approach to address, according to Doug Nemecek, MD, MBA, CMO of behavioral health for Bloomfield, Conn.–based Cigna.
The number of Americans dying from opioid overdoses is staggering. In 2015, a record 52,404 people in the U.S. died from drug overdoses. The rise in deaths was largely driven the 33,000 deaths attributable to opioids — a record number,…
